Related Experiment Videos
Dopamine D4 receptors: beyond schizophrenia
Frank I Tarazi1, Kehong Zhang, Ross J Baldessarini
1Mailman Research Center, McLean Division of Massachusetts General Hospital, Belmont, Massachusetts, USA. ftarazi@hms.harvard.edu
Journal of Receptor and Signal Transduction Research
|November 4, 2004
Summary
Dopamine D4 receptors are implicated in neuropsychiatric disorders beyond schizophrenia, showing potential for treating conditions like ADHD and personality traits. Selective D4 agents may offer new therapeutic options.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Dopamine D4 receptors are crucial for neuronal signaling, with dysfunctions linked to neuropsychiatric disorders.
- Existing research on D4 receptors and schizophrenia has yielded inconclusive results.
- Current D4 antagonists have shown limited efficacy in treating schizophrenia symptoms.
Purpose of the Study:
- To explore the broader implications of dopamine D4 receptors in neuropsychiatric disorders.
- To investigate the role of D4 receptors in conditions beyond psychosis, such as ADHD and personality traits.
- To assess the potential of selective D4 receptor agents as therapeutic interventions.
Main Methods:
- Review of postmortem neuropathological and genetic studies.
- Analysis of clinical trial data for D4 receptor antagonists.
- Examination of preclinical studies on D4 receptor function.
Main Results:
- D4 receptor associations are emerging in attention-deficit hyperactivity disorder and novelty-seeking personality traits.
- Preclinical data highlight D4 receptors' role in hyperactivity, impulsivity, and working memory.
- Schizophrenia associations remain inconclusive, and D4 antagonists have not proven effective for psychotic symptoms.
Conclusions:
- Dopamine D4 receptors have wider implications for human illnesses than initially thought, extending beyond schizophrenia.
- Selective D4 receptor agents show promise for developing novel treatments for various neuropsychiatric disorders.
- Further research into D4 receptor modulation could lead to improved therapies for conditions requiring better treatment options.